Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Lake Street Best Ideas Growth Conference, and Cantor Global Healthcare Conference
SAN FRANCISCO, Aug. 28, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the H.C. Wainwright Global Investment Conference on September 10, the Lake Street Best Ideas Growth Conference on September 12, and the Cantor Global Healthcare Conference on October 2, in New York City. During this time, investors will have the opportunity to discuss recent developments, including the launch of KindredBio's first product, study results from key therapeutic programs in development, and upcoming milestones. Conference Details: H.C. Wainwright Global Investment Conference Date: Tuesday, September 10, 2019 KindredBio participant: CEO Richard Chin Presentation time: 8:20-8:45a.m. ET in Adams, 4th Fl Location: Lotte New York Palace Hotel Webcast URL: Click here Lake Street Best Ideas Growth Conference Date: Thursday, September 12, 2019 KindredBio participant: CEO Richard Chin Location: Parker New York Cantor Global Healthcare Conference Date: Wednesday, October 2, 2019 KindredBio participant: President and COO Denise Bevers Presentation time: 9:30-10:00a.m ET in Track 5 - Empire Ballroom 2 Location: InterContinental New York Barclay Webcast URL: Click here An archived version of the above webcasts will be available for 30 days on the KindredBio website. About Kindred Biosciences Important Safety Information Contact View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-participate-in-hc-wainwright-global-investment-conference-lake-street-best-ideas-growth-conference-and-cantor-global-healthcare-conference-300908049.html SOURCE Kindred Biosciences, Inc. |
||
Company Codes: NASDAQ-SMALL:KIN |